The central serotonin2B receptor: A new pharmacological target to modulate the mesoaccumbens dopaminergic pathway activity

Journal of Neurochemistry

Volumn 114, Issue 5, 2010, Pages 1323-1332

  Auclair, Agnès L ^a   Cathala, Adeline ^b,c   Sarrazin, Frédéric ^b,c   Depoortère, Ronan ^a   Piazza, Pier Vincenzo ^b,c   Newman Tancredi, Adrian ^a   Spampinato, Umberto ^b,c  

^a INSTITUT DE RECHERCHE PIERRE FABRE   (France)

^b INSTITUT FRANÇOIS MAGENDIE   (France)

^c UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

5 HT2B receptor; amphetamine; dopamine release; haloperidol; nucleus accumbens; striatum

Indexed keywords

1 [(2 CHLORO 3,4 DIMETHOXYPHENYL)METHYL] 2,3,4,9 TETRAHYDRO 6 METHYL 1H PYRIDO[3,4 B]INDOLE; 1 [5 (2 THIENYLMETHOXY) 3 INDOLYL] 2 PROPANAMINE; 1,2,3,5 TETRAHYDRO 5 METHYL 1 (3 PYRIDYLCARBAMOYL)PYRROLO[2,3 F]INDOLE; 2 AMINO 4 (4 FLUORONAPHTH 1 YL) 6 ISOPROPYLPYRIMIDINE; 5 METHYL 1 (3 PYRIDYLCARBAMOYL) 1,2,3,5 TETRAHYDROPYRROLO[2,3 F] INDOLE; AMPHETAMINE; HALOTHANE; LY 266097; RS 127445; SEROTONIN 2 ANTAGONIST; SEROTONIN 2B RECEPTOR; SEROTONIN 2C AGONIST; UNCLASSIFIED DRUG;

ANESTHESIA; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC ACTIVITY; DRUG TARGETING; IN VIVO STUDY; LOCOMOTION; MALE; MICRODIALYSIS; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT;

ANIMALS; DOPAMINE; DRUG DELIVERY SYSTEMS; MALE; MOTOR ACTIVITY; NUCLEUS ACCUMBENS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT2B; SEROTONIN ANTAGONISTS; SIGNAL TRANSDUCTION;

MAMMALIA; RATTUS;

EID: 77954132615     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2010.06848.x     Document Type: Article

References (47)

1. Adachi Y., Uchihashi Y., Watanabe K. Satoh T. (2000) Halothane anesthesia decreases the extracellular level of dopamine in rat striatum: a microdialysis study in vivo. J. Anesth. 14, 82 90. (Pubitemid 30440503)
2. Alex K. D. Pehek E. A. (2007) Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission. Pharmacol. Ther. 113, 296 320.
3. Audia J. E., Evrard D. A., Murdoch G. R. et al. (1996) Potent, selective tetrahydro-beta-carboline antagonists of the serotonin 2B (5HT2B) contractile receptor in the rat stomach fundus. J. Med. Chem. 39, 2773 2780.
4. Bardin L., Auclair A. L., Kleven M. S., Prinssen E. P., Koek W., Newman-Tancredi A. Depoortère R. (2007) Pharmacological profiles in rats of novel antipsychotics with combined dopamine D2/serotonin 5-HT1A activity: comparison with typical and atypical conventional antipsychotics. Behav. Pharmacol. 18, 103 118.
5. Berg K. A., Clarke W. P., Cunningham K. A. Spampinato U. (2008) Fine-tuning serotonin2C receptor function in the brain: molecular and functional implications. Neuropharmacology 55, 969 976.
6. Bonaventure P., Guo H., Tian B. et al. (2002) Nuclei and subnuclei gene expression profiling in mammalian brain. Brain Res. 943, 38 47.
7. Bonhaus D. W., Flippin L. A., Greenhouse R. J. et al. (1999) RS-127445: a selective, high affinity, orally bioavailable 5-HT2B receptor antagonist. Br. J. Pharmacol. 127, 1075 1082.
8. Bubar M. J. Cunningham K. A. (2008) Prospects for serotonin 5-HT2R pharmacotherapy in psychostimulant abuse. Prog. Brain Res. 172, 319 346.
9. Bunney B. S., Walters J. R., Roth R. H. Aghajanian G. K. (1973) Dopaminergic neurons: effect of antipsychotic drugs and amphetamine on single cell activity. J. Pharmacol. Exp. Ther. 185, 560 571.
10. Carboni E., Imperato A., Perezzani L. Di Chiara G. (1989) Amphetamine, cocaine, phencyclidine and nomifensine increase extracellular dopamine concentrations preferentially in the nucleus accumbens of freely moving rats. Neuroscience 28, 653 661.
11. De Deurwaerdere P., Navailles S., Berg K. A., Clarke W. P. Spampinato U. (2004) Constitutive activity of the serotonin2C receptor inhibits in vivo dopamine release in the rat striatum and nucleus accumbens. J. Neurosci. 24, 3235 3241.
12. De Deurwaerdère P., Moison D., Navailles S., Porras G. Spampinato U. (2005) Regionally and functionally distinct serotonin3 receptors control in vivo dopamine outflow in the rat nucleus accumbens. J. Neurochem. 94, 140 149.
13. Di Chiara G. (2002) Nucleus accumbens shell and core dopamine: differential role in behavior and addiction. Behav. Brain Res. 137, 75 114.
14. Di Chiara G. Imperato A. (1988) Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl Acad. Sci. 85, 5274 5278.
15. Di Chiara G., Bassareo V., Fenu S. et al. (2004) Dopamine and drug addiction: the nucleus accumbens shell connection. Neuropharmacology 47 (Suppl 1 227 241.
16. Di Matteo V., Di Giovanni G., Di Mascio M. Esposito E. (2000) Biochemical and electrophysiological evidence that RO 60-0175 inhibits mesolimbic dopaminergic function through serotonin(2C) receptors. Brain Res. 865, 85 90.
17. Di Matteo V., Pierucci M., Esposito E., Crescimanno G., Benigno A. Di Giovanni G. (2008) Serotonin modulation of the basal ganglia circuitry: therapeutic implication for Parkinson's disease and other motor disorders. Prog. Brain Res. 172, 423 463.
18. Doly S., Valjent E., Setola V., Callebert J., Hervé D., Launay J. M. Maroteaux L. (2008) Serotonin 5-HT2B receptors are required for 3,4-methylenedioxymethamphetamine-induced hyperlocomotion and 5-HT release in vivo and in vitro. J. Neurosci. 28, 2933 2940.
19. Doly S., Bertran-Gonzalez J., Callebert J. et al. (2009) Role of serotonin via 5-HT2B receptors in the reinforcing effects of MDMA in mice. PLoS ONE 4, e7952.
20. Dunnett S. B. Robbins T. W. (1992) The functional role of mesotelencephalic dopamine systems. Biol. Rev. Camb. Philos. Soc. 67, 491 518.
21. Duxon M. S., Flanigan T. P., Reavley A. C., Baxter G. S., Blackburn T. P. Fone K. C. (1997) Evidence for expression of the 5-hydroxytryptamine-2B receptor protein in the rat central nervous system. Neuroscience 76, 323 329.
22. Gleason S. D., Lucaites V. L., Shannon H. E., Nelson D. L. Leander J. D. (2001) m-CPP hypolocomotion is selectively antagonized by compounds with high affinity for 5-HT(2C) receptors but not 5-HT(2A) or 5-HT(2B) receptors. Behav. Pharmacol. 12, 613 620.
23. Gobert A., Rivet J. M., Lejeune F., Newman-Tancredi A., Adhumeau-Auclair A., Nicolas J. P., Cistarelli L., Melon C. Millan M. J. (2000) Serotonin(2C) receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: a combined dialysis and electrophysiological analysis in the rat. Synapse 36, 205 221.
24. Hall D. A., Stanis J. J., Avila H. M. Gulley J. M. (2008) A comparison of amphetamine- and methamphetamine-induced locomotor activity in rats: evidence for qualitative differences in behavior. Psychopharmacology 195, 469 478.
25. Kennett G. A., Bright F., Trail B., Baxter G. S. Blackburn T. P. (1996a) Effects of the 5-HT2B receptor agonist, BW 723C86, on three rat models of anxiety. Br. J. Pharmacol. 117, 1443 1448.
26. Kennett G. A., Wood M. D., Bright F. et al. (1996b) In vitro and in vivo profile of SB 206553, a potent 5-HT2C/5-HT2B receptor antagonist with anxiolytic-like properties. Br. J. Pharmacol. 117, 427 434.
27. Kennett G. A., Ainsworth K., Trail B. Blackburn T. P. (1997) BW 723C86, a 5-HT2B receptor agonist, causes hyperphagia and reduced grooming in rats. Neuropharmacology 36, 233 239.
28. Kennett G. A., Trail B. Bright F. (1998) Anxiolytic-like actions of BW 723C86 in the rat Vogel conflict test are 5-HT2B receptor mediated. Neuropharmacology 37, 1603 1610.
29. Launay J. M., Schneider B., Loric S., Da Prada M. Kellermann O. (2006) Serotonin transport and serotonin transporter-mediated antidepressant recognition are controlled by 5-HT2B receptor signaling in serotonergic neuronal cells. FASEB J. 20, 1843 1854.
30. Leggio G. M., Cathala A., Moison D., Cunningham K. A., Piazza P. V. Spampinato U. (2009) Serotonin(2C) receptors in the medial prefrontal cortex facilitate cocaine-induced dopamine release in the rat nucleus accumbens. Neuropharmacology 56, 507 513.
31. 2 Receptors. Curr. Drug Targets CNS Neurol. Disord. 3, 11 26.
32. Liégeois J. F., Ichikawa J. Meltzer H. Y. (2002) 5-HT(2A) receptor antagonism potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and inhibits that in the nucleus accumbens in a dose-dependent manner. Brain Res. 947, 157 165.
33. 2C receptor subtypes and significance of the haloperidol dose used. Neuropharmacology 39, 1053 1063.
34. 4 receptors exert a state-dependent facilitatory control in vivo on nigrostriatal, but not mesoaccumbal, dopaminergic function. Eur. J. Neurosci. 13, 889 898.
35. Martel J. C., Cussac D., Assie M. B., Rauly-Lestienne I. Newman-Tancredi A. (2006) Antagonism by atypical benzamide antipsychotics of serotonin 5-HT2B receptors: comparison with 5-HT2A, 5-HT2C and dopamine D2 receptors. Soc. Neurosci. Abstr. 32, 93 98.
36. Meltzer H. Y. Huang M. (2008) In vivo actions of atypical antipsychotic drug on serotonergic and dopaminergic systems. Prog. Brain Res. 172, 177 197.
37. Mereu G., Fanni B. Gessa G. L. (1984) General anesthetics prevent dopaminergic neuron stimulation by neuroleptics. in Catecholamines: Neuropharmacology and Central Nervous System-Theoretical Aspects (Usdin E., Carlsson A., Dahlstrom A., Engel J., eds), pp. 353 358. Alan. R. Liss. Inc., New York.
38. Millan M. J. (2009) Dual- and triple-acting agents for treating core and co-morbid symptoms of major depression: novel concepts, new drugs. Neurotherapeutics 6, 53 77.
39. Navailles S., De Deurwaerdère P. Spampinato U. (2006) Clozapine and haloperidol differentially alter the constitutive activity of central serotonin2C receptors in vivo. Biol. Psychiatry 59, 568 575. (Pubitemid 43320546)
40. Navailles S., Moison D., Cunningham K. A. Spampinato U. (2008) Differential regulation of the mesoaccumbens dopamine circuit by serotonin2C receptors in the ventral tegmental area and the nucleus accumbens: an in vivo microdialysis study with cocaine. Neuropsychopharmacology 33, 237 246.
41. Paxinos G. Watson C. (1986) The rat brain in stereotaxic coordinates. Academic press, New York.
42. Porras G., Di Matteo V., De Deurwaerdere P., Esposito E. Spampinato U. (2002a) Central serotonin4 receptors selectively regulate the impulse-dependent exocytosis of dopamine in the rat striatum: in vivo studies with morphine, amphetamine and cocaine. Neuropharmacology 43, 1099 1109.
43. 2C/2B receptor subtypes modulate dopamine release induced in vivo by amphetamine and morphine in both the rat nucleus accumbens and striatum. Neuropsychopharmacology 26, 311 324.
44. Porras G., De Deurwaerdère P., Moison D. Spampinato U. (2003) Conditional involvement of striatal serotonin3 receptors in the control of in vivo dopamine outflow in the rat striatum. Eur. J. Neurosci. 17, 771 781.
45. Schapira A. H., Bezard E., Brotchie J. et al. (2006) Novel pharmacological targets for the treatment of Parkinson's disease. Nat. Rev. Drug Discov. 5, 845 854.
46. Schmidt C. J., Fadayel G. M., Sullivan C. K. Taylor V. L. (1992) 5-HT2 receptors exert a state-dependent regulation of dopaminergic function: studies with MDL 100,907 and the amphetamine analogue, 3,4- methylenedioxymethamphetamine. Eur. J. Pharmacol. 223, 65 74.
47. Shapiro D. A., Renock S., Arrington E., Chiodo L. A., Liu L. X., Sibley D. R., Roth B. L. Mailman R. (2003) Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology. Neuropsychopharmacology 28, 1400 1411.